Cataract / Glaucoma / Pseudoexfoliation syndrome / Exfoliation glaucoma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with cataract, glaucoma, pseudoexfoliation syndrome, or exfoliation glaucoma and undergoing cataract or glaucoma surgery
Exclusion criteria
Exclusion criteria: The patient and/or his/her substitute decision-maker do not provide informed consent for participation in this study, or the patient's ophthalmologist decides not to allow the patient to participate in this study based on the patient's ocular condition.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amyloid-beta 1-40 and Amyloid-beta 1-42 concentrations in the aqueous humor collected at the start of cataract or glaucoma surgery and measured using Sensitive and specific enzyme-linked immunosorbent assay (ELISA) | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlations between Amyloid-beta 1-40 and Amyloid-beta 1-42 concentrations and retinal nerve fiber layer thickness and degree of visual field loss | — |
Countries
Japan
Contacts
Ohashi Eye Center President